메뉴 건너뛰기




Volumn 36, Issue 1, 2001, Pages 194-196

Disialoganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma

Author keywords

3F8; 131I 3F8; Gangliosides; Immunotherapy

Indexed keywords

GANGLIOSIDE GD2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3F8; MONOCLONAL ANTIBODY I 131; UNCLASSIFIED DRUG; 3F8 ANTIBODY; ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; GANGLIOSIDE; GANGLIOSIDE, GD2; IMMUNOGLOBULIN G; RADIOACTIVE IODINE; TUMOR ANTIGEN; TUMOR MARKER;

EID: 0034746989     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20010101)36:1<194::AID-MPO1046>3.0.CO;2-B     Document Type: Conference Paper
Times cited : (30)

References (10)
  • 1
    • 0030000146 scopus 로고    scopus 로고
    • Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: Evidence for immunoselection of antigen-loss variants in vivo
    • (1996) Int J Cancer , vol.66 , pp. 470-476
    • Knath, A.1
  • 2
    • 0011202141 scopus 로고
    • Antibodies in cancer therapy: B-cell lymphomas
    • De Vita VT, Hellman S, Rosenberg SA, editors. Biologic therapy of cancer. Philadelphia, PA: J.B. Lippincott
    • (1991)
    • Levy, R.1
  • 10
    • 0006596873 scopus 로고
    • Neuroblastomata: With a study of case illustrating the three types that arise from the sympathetic system
    • (1914) J Med Res , vol.30 , pp. 205
    • Wahl, H.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.